1.25 semaglutide Oral Wegovy approved for obesity management by FDA on December 23, 2025 Formulation: High‑dose oral (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) This medication is used with a doctor Novo Nordisk offers Ozempic for

Please enter your contact details below and the reason for your discovery call and we will get back to you to arrange a suitable time for your FREE 15 Minute Discovery Call

More direct head-to-head studies will be needed to confirm how it really stacks up against other weight-loss medications

Heres a step-by-step look at how the process works at SOMA, from your initial consultation to ongoing support

Over time, the dosage can be increased to help achieve the best possible weight loss and blood sugar control results

Eli Lilly, the firm that makes Mounjaro, said patient safety was its "top priority", adding that it actively reports safety information to the MHRA and encourages "healthcare professionals and others" to do the same via the Yellow Card scheme

Reveal your most radiant, luminous complexion with glutathione the body's master antioxidant, delivered directly via injection for maximum potency